S017 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness
DESCRIPTION
This session will examine the data and provide an evidenced based discussion about best cost effective practices to care for patients with photoaging, acne, psoriasis, HS, as well as hair and nail disease.
This session will provide an opportunity to review and apply some time-honored strategies, as well as a few new ones, to the factors that make our lives feel out of control. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org
LEARNING OBJECTIVES
Assess cost effective care of various skin diseases and conditions including photoaging, acne, hair and nail disease, among others.
Examine evidence that drives decision making for skin disease such as psoriasis and HS.
SCHEDULE
1:00 PM
Psoriasis: Improving outcomes and cost-effective care
Joel M. Gelfand, MD, MSCE, FAAD
1:35 PM
Cost Effective Care of Acne
John S. Barbieri, MD, MBA, FAAD
2:05 PM
Cost Effective Care of Hidradenitis Suppurativa
Joslyn S Kirby, MD, FAAD
2:35 PM
Best Cost Effective Care of Nail Disease
Brian William Morrison, MD, MSc, FAAD
3:00 PM
Cost Effective Care of Hair Loss
Mariya Miteva, MD
3:30 PM
Photo-aging: Evidenced Based Cost Effective Care
Shasa Hu, MD, FAAD
DIRECTOR
Scott Elman, MD, FAAD
SPEAKERS
John S. Barbieri, MD, MBA, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Shasa Hu, MD, FAAD
Joslyn S Kirby, MD, FAAD
Mariya Miteva, MD
Brian William Morrison, MD, MSc, FAAD
HANDOUTS
DISCLOSURES
John S. Barbieri, MD, MBA, FAAD
Alosa Health – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Honeydew Care – Consultant (1099 relationship)(Fees); Kenvue – Consultant (1099 relationship)(Fees); National Institutes of Health – Other(Grants/Research Funding); National Psoriasis Foundation – Other(Grants/Research Funding); Sagimet Biosciences – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); TWi Biotechnology, Inc. – Consultant (1099 relationship)(Fees);
Scott Elman, MD, FAAD
Biogen – Consultant(Fees); Blueprint Medicines – Advisory Board(Fees); EMD Serono – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding);
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Alumis – Consultant (1099 relationship)(Fees); Alyson Oliver Partner & Attorney – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Arnold & Porter – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);
Shasa Hu, MD, FAAD
BPG bio – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Consultant(Honoraria); Swiss American – Consultant(Honoraria);
Joslyn S Kirby, MD, FAAD
Incyte Corporation – Consultant (1099 relationship)(Fees), Employee (w-2 relationship)(Salary); Penn State University – Other(Patent royalties or other compensation for Intellectual Property Rights);
Mariya Miteva, MD
Absci – Advisory Board(Honoraria); Cassiopea, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Informa – Other(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Brian William Morrison, MD, MSc, FAAD
No financial relationships exist with ineligible companies.